Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × NETWORK × Ketoconazole × Clear all

Phase

Phase 3 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 9 OTHER 4 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Neuroblastoma 1

Interventions

Cisplatin 20 Radiotherapy 15 Paclitaxel 15 Carboplatin 15 Cyclophosphamide 13 Vincristine 12 Etoposide 11 Filgrastim 10 Doxorubicin 10 Gemcitabine 9 Docetaxel 8 Topotecan 7 Dexamethasone 7 Temozolomide 6 Granulocyte Colony-Stimulating Factor 6 Cytarabine 6 Radiation 5 Peripheral Blood Stem Cell Transplantation 5 Oxaliplatin 5 Methotrexate 5 Melphalan 5 Fenretinide 5 Capecitabine 5 etoposide phosphate 4 Trastuzumab 4 Taxes 4 Radiotherapy, Conformal 4 Pemetrexed 4 Leucovorin 4 Lapatinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02163356 2022-03-31

SPOC2013-001

South Plains Oncology Consortium

Phase 1 Terminated

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡